 CAMBRIDGE, Mass.--BUSINESS WIRE--Aura Biosciences Inc. NASDAQ: AURA, a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate VDC therapies for multiple oncology indications, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer of Aura will present at the 2022 Bank of America Healthcare Conference. The conference is being held in Las Vegas, Nevada and the presentation will take place on Tuesday, May 10, 2022, at 4:55 p.m. PT. A live 